MAP microba life sciences limited

As per Bells today :Microba (MAP) today announce additional...

  1. 10,126 Posts.
    lightbulb Created with Sketch. 1041
    As per Bells today :

    Microba (MAP) today announce additional distribution agreements with SYNLAB affiliate organisations in Türkiye (formerly Turkey) and Czech Republic

    Back in 2020, SYNLAB International GmbH and SYNLAB Diagnosticos Globales signed a distribution agreement with MAP to deliver Microba’s gut health tests to Healthcare Providers in Spain, with an option to formalise distribution agreements across their affiliate organisations. In December last year we communicated the activation of this option into Italy and Portugal. Synlab has now activated further agreements by way of its affiliate organisations Referans M-B Saglik Labopratuvar and SYNLAB czech s.r.o., to distribute Microba’s testing technology into Türkiye and Czech Republic respectively (non-exclusive distribution rights out to 31 December 2028).

    This evolving distribution expansion is testament to MAPs significance as a leading gut health testing and precision microbiome company.

    We currently have a Buy (Spec.) recommendation and a valuation of $0.60 p/s on the stock.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.3¢
Change
0.001(1.09%)
Mkt cap ! $47.89M
Open High Low Value Volume
9.3¢ 9.3¢ 9.3¢ $2.79K 30K

Buyers (Bids)

No. Vol. Price($)
5 20774 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 114482 1
View Market Depth
Last trade - 11.50am 30/07/2025 (20 minute delay) ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.